Frutarom to Market Novel Curcumin Product
14 Nov 2013 --- Frutarom Switzerland Ltd., Health BU, has joined forces with Aquanova AG, the German pharma GMP manufacturer of superior ingredient formulas, to market NovaSOL Curcumin, a solubilized, highly bioavailable form of curcumin for the dietary supplement and food manufacturing industries.
Frutarom Health will work in collaboration with Molecular Health Technologies, its current sales and marketing agent in the US and Canadian markets.
Curcumin, the yellow pigment and primary nutraceutical compound found in turmeric, is used as a coloring agent by the food industry, and as an active phytochemical in nutraceuticals. Curcumin has a broad, scientifically well-documented spectrum of health benefits due to its powerful anti-inflammatory and antioxidant properties. There is increasing awareness among consumers regarding the benefits of this ingredient backed by scientific data. The market for curcumin products is expanding rapidly.
Curcumin’s traditionally low bioavailability had been a major challenge that led to the use of inconveniently high dosages, especially in its powder form. These amounts did not match the amount of curcumin used in third-party clinical trials to achieve the desired health benefits.
NovaSOL Curcumin is a highly bioavailable curcumin formulation. It was developed as part of a major European research project funded by the German Federal Ministry of Education and Research.
The proprietary NovaSOL curcumin technology offers a liquid, crystal-clear, yellow solution for use across a wide variety of applications.
As a result, the curcumin becomes fully water soluble, a quality that affects superior bioavailability. A human clinical trial, to be published later this year, demonstrated impressive absorption rate and bioavailability in comparison with both standard curcumin extracts and other improved turmeric formulas.
“The demand for anti-inflammatory ingredients, and the growing amount of scientific evidence on the health benefits of curcumin, will continue to drive the sales of turmeric preparations,” avers Wouter Haazen, Product Manager for the Frutarom Health Business Unit. “Bioavailability and correct dosage are important factors for this ingredient. This unique formula enables our customers to create highly potent, small-dose products to benefit consumers. The new technology, scientific support and unique properties of NovaSOL Curcumin make it a welcome addition to our product portfolio.”
“We are overwhelmed by the research results, and the fact that our technology has proven its ability to boost curcumin absorption, owed to the nature like structure, that NovaSOL creates for highly lipophilic actives such as Curcumin,“ adds Frank Behnam, Business Development Manager for Aquanova. “Due to the extremely valuable health benefits, we are convinced that NovaSOL Curcumin will open a path for manufacturers to create sophisticated and sustainable healthcare and functional products.”
